Literature DB >> 7540976

Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A.

M E Cardenas1, R S Muir, T Breuder, J Heitman.   

Abstract

The immunosuppressive complexes cyclophilin A-cyclosporin A (CsA) and FKBP12-FK506 inhibit calcineurin, a heterodimeric Ca(2+)-calmodulin-dependent protein phosphatase that regulates signal transduction. We have characterized CsA- or FK506-resistant mutants isolated from a CsA-FK506-sensitive Saccharomyces cerevisiae strain. Three mutations that confer dominant CsA resistance are single amino acid substitutions (T350K, T350R, Y377F) in the calcineurin A catalytic subunit CMP1. One mutation that confers dominant FK506 resistance alters a single residue (W430C) in the calcineurin A catalytic subunit CMP2. In vitro and in vivo, the CsA-resistant calcineurin mutants bind FKBP12-FK506 but have reduced affinity for cyclophilin A-CsA. When introduced into the CMP1 subunit, the FK506 resistance mutation (W388C) blocks binding by FKBP12-FK506, but not by cyclophilin A-CsA. Co-expression of CsA-resistant and FK506-resistant calcineurin A subunits confers resistance to CsA and to FK506 but not to CsA plus FK506. Double mutant calcineurin A subunits (Y377F, W388C CMP1 and Y419F, W430C CMP2) confer resistance to CsA, to FK506 and to CsA plus FK506. These studies identify cyclophilin A-CsA and FKBP12-FK506 binding targets as distinct, highly conserved regions of calcineurin A that overlap the binding domain for the calcineurin B regulatory subunit.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540976      PMCID: PMC398395          DOI: 10.1002/j.1460-2075.1995.tb07277.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  62 in total

1.  Getting started with yeast.

Authors:  F Sherman
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites.

Authors:  R D Gietz; A Sugino
Journal:  Gene       Date:  1988-12-30       Impact factor: 3.688

3.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

4.  A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains.

Authors:  E Alani; L Cao; N Kleckner
Journal:  Genetics       Date:  1987-08       Impact factor: 4.562

5.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

6.  Sensitivity to cyclosporin A is mediated by cyclophilin in Neurospora crassa and Saccharomyces cerevisiae.

Authors:  M Tropschug; I B Barthelmess; W Neupert
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

7.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

8.  Yeast has homologs (CNA1 and CNA2 gene products) of mammalian calcineurin, a calmodulin-regulated phosphoprotein phosphatase.

Authors:  M S Cyert; R Kunisawa; D Kaim; J Thorner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

9.  Regulation of calcineurin phosphatase activity and interaction with the FK-506.FK-506 binding protein complex.

Authors:  J N Parsons; G J Wiederrecht; S Salowe; J J Burbaum; L L Rokosz; R L Kincaid; S J O'Keefe
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

10.  A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae.

Authors:  R S Sikorski; P Hieter
Journal:  Genetics       Date:  1989-05       Impact factor: 4.562

View more
  40 in total

1.  Comparison of the roles of calcineurin in physiology and virulence in serotype D and serotype A strains of Cryptococcus neoformans.

Authors:  M C Cruz; R A Sia; M Olson; G M Cox; J Heitman
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Early Minocycline and Late FK506 Treatment Improves Survival and Alleviates Neuroinflammation, Neurodegeneration, and Behavioral Deficits in Prion-Infected Hamsters.

Authors:  Syed Zahid Ali Shah; Deming Zhao; Giulio Taglialatela; Sher Hayat Khan; Tariq Hussain; Haodi Dong; Mengyu Lai; Xiangmei Zhou; Lifeng Yang
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

3.  Molecular modeling of the calmodulin binding region of calcineurin.

Authors:  John D Hoekman; Abigail M Tokheim; Donna J Spannaus-Martin; Bruce L Martin
Journal:  Protein J       Date:  2006-04       Impact factor: 2.371

4.  Competitive inhibition of calcineurin phosphatase activity by its autoinhibitory domain.

Authors:  J K Sagoo; D A Fruman; S Wesselborg; C T Walsh; B E Bierer
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

Review 5.  Calcineurin signaling in the heart: The importance of time and place.

Authors:  Valentina Parra; Beverly A Rothermel
Journal:  J Mol Cell Cardiol       Date:  2016-12-20       Impact factor: 5.000

6.  Calcineurin is essential for survival during membrane stress in Candida albicans.

Authors:  M Cristina Cruz; Alan L Goldstein; Jill R Blankenship; Maurizio Del Poeta; Dana Davis; Maria E Cardenas; John R Perfect; John H McCusker; Joseph Heitman
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

7.  Calcineurin is required for virulence of Cryptococcus neoformans.

Authors:  A Odom; S Muir; E Lim; D L Toffaletti; J Perfect; J Heitman
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

8.  Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes.

Authors:  G Werlen; E Jacinto; Y Xia; M Karin
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

Review 9.  Signaling cascades as drug targets in model and pathogenic fungi.

Authors:  Robert J Bastidas; Jennifer L Reedy; Helena Morales-Johansson; Joseph Heitman; Maria E Cardenas
Journal:  Curr Opin Investig Drugs       Date:  2008-08

10.  A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants.

Authors:  Antonio Rodríguez; Jagoree Roy; Sara Martínez-Martínez; María Dolores López-Maderuelo; Perla Niño-Moreno; Leticia Ortí; David Pantoja-Uceda; Antonio Pineda-Lucena; Martha S Cyert; Juan Miguel Redondo
Journal:  Mol Cell       Date:  2009-03-13       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.